Octreotide prevents the pathological alterations of bowel obstruction in cancer patients.
Mercadante
S
S
Avola
G
G
Maddaloni
S
S
Salamone
G
G
Aragona
F
F
Rodolico
V
V
D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007415:Intestinal Obstruction / Q000188:drug therapy* / Q000209:etiology / Q000601:surgery*; D007422:Intestines / Q000187:drug effects / Q000473:pathology; D009369:Neoplasms / Q000150:complications / Q000601:surgery; D015282:Octreotide / Q000008:administration & dosage / Q000627:therapeutic use*; D011300:Preoperative Care
D005765:Gastrointestinal Agents; D015282:Octreotide